High HGF Levels are Associated with Response to Bortezomib

• Authors: ŠVÁCHOVÁ Hana; POUR Luděk; KRÁLOVÁ Dana; NĚMEC Pavel; ADAM Zdeněk; KREJČÍ Marta; SANDECKÁ Viera; KŘIVANOVÁ Andrea; AL SAHMANI Mohamed; HÁJEK Roman
• Year of publication: 2009
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: Our previous studies have demonstrated elevated levels of angiogenesis activators such as hepatocyte growth factor (HGF) in the serum of MM patients as negative prognostic value. The aim of this study was to define the role of HGF in peripheral plasma (PP) in MM patients undergoing Bortezomib treatment and its influence on treatment response.

Related projects

• University Research Centre - Czech Myeloma Group
• From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies